Hence, this study aims to establish and validate the FL‐CD animal model, deeply evaluate the expression dynamics of LXRβ in the pathological process of FL‐CD, and explore its possible regulatory role in glial cell function and cortical structural abnormalities, to uncover novel molecular insights into the pathogenesis of FCD. The gene discussed is NR1H2; the disease is fleck corneal dystrophy.